A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

NCT05388474 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections
Multi-Antiviral Resistance

Interventions

OTHER: No ibalizumab or Pre-ibalizumab treatment
BIOLOGICAL: On ibalizumab treatment

Sponsor

Theratechnologies

Collaborators

[object Object]
[object Object]
[object Object]